Detalhe da pesquisa
1.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914339
2.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867034
3.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(12): 1688-1700, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146401
4.
Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
Histopathology
; 70(2): 185-194, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402148
5.
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(3): 367-377, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26874901
6.
Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor.
Breast Cancer Res Treat
; 155(3): 483-90, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26846986
7.
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.
Breast Cancer Res Treat
; 146(1): 153-62, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24924416
8.
Optimizing Postneoadjuvant Treatment in Patients With Early Breast Cancer Achieving Pathologic Complete Response.
J Clin Oncol
; : JCO2301935, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569132
9.
Sequencing of Endocrine and Targeted Therapies in Hormone-Sensitive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
J Clin Oncol
; 41(24): 3976-3983, 2023 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37406271
10.
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Eur J Cancer
; 184: 48-59, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898233
11.
Proteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes.
Nat Commun
; 13(1): 896, 2022 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173148
12.
Safety, pharmacokinetics, and efficacy of CPX-1 liposome injection in patients with advanced solid tumors.
Clin Cancer Res
; 15(2): 692-700, 2009 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19147776